PAQR3 inhibits proliferation via suppressing PI3K/AKT signaling pathway in non-small cell lung cancer.
Conclusions: Our findings suggest that PAQR3 is a tumor suppressor in the development of NSCLC and may serve as a novel therapeutic target in the treatment of patients with NSCLC.
PMID: 30393483 [PubMed]
Source: Archives of Medical Science - Category: Biomedical Science Tags: Arch Med Sci Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Science | Study